Announcement
Caris Life Sciences Strategically Collaborates with Ontada to Advance Oncology Research and the Adoption of Precision Medicine
Caris Life Sciences
PR-01-25-NI-21Jan 20, 2025
Funding
Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform
Caris Life Sciences
PR-M05-21-009May 13, 2021
Drug Target
Caris Life Sciences Identifies a Splicing Complex on the Surface of Non-Hodgkin's Lymphoma Cells that Is a Potential Anti-Tumor Drug Target
Caris Life Sciences
PR-M04-19-NI-003Apr 01, 2019